Marijuana and cocaine impair alveolar macrophage function and cytokane production

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 5, 1997, Pages 1606-1613

  Baldwin, Gayle Cocita ^b   Tashkin, Donald P ^b   Buckley, Dawn M ^b   Park, Alice N ^b   Dubinett, Steven M ^b   Roth, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; COCAINE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; SMOKING; STAPHYLOCOCCUS AUREUS; TOBACCO; TUMOR CELL LINE;

EID: 0030665501     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.5.9704146     Document Type: Article

References (70)

1. Johnston, L. D., P. M. O'Malley, and J. G. Bachman. 1996. National survey on drug use from the Monitoring the Future Study, 1975-1993. Vol. 1: Secondary School Students, Vol. II: College Students and Young Adults. National Institute on Drug Abuse, Government Printing Office, Washington, DC. NIH Publication No. 94-3809.
2. Kassirer, J. P. 1997. Federal foolishness and marijuana. N. Engl. J. Med. 336:366-367.
3. Grinspoon, L., and J. B. Bakalar. 1995. Marihuana as medicine: a plea for reconsideration. J.A.M.A. 273:1875-1876.
4. Tashkin, D. P., A. H. Coulson, V. A. Clark, M. Simmons, L. B. Bourque, S. Duann, G. H. Spivey, and H. Gong. 1987. Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone and nonsmokers. Am. Rev. Respir. Dis. 135:209-216.
5. Barbers, R. G., H. Gong, D. P. Tashkin, J. Oishi, and J. M. Wallace. 1987. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am. Rev. Respir. Dis. 135:1271-1275.
6. Thadani, P. 1996. Conference report on cardiopulmonary complications of "crack" cocaine use: clinical manifestations and pathophysiology. Chest 110:1072-1076.
7. Bouaboula, M., M. Rinaldi, P. Carayon, C. Carillon, B. Delpech, D. Shire, G. Le Fur, and O. Casellas. 1993. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:173-180.
8. 9-tetrahydrocannabinol injection. Infect. Immun. 62:4015-4020.
9. Klein, T. W., Y. Kawakami, C. Newton, and H. Friedman. 1991. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Environ. Health 32:465-477.
10. Kusher, D. I., L. O. Dawson, A. C. Taylor, and J. Y. Djeu. 1994. Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell. Immunol. 154:99-108.
11. Burnette-Curley, D., and G. A. Cabral. 1995. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9-tetrahydrocannabinol. Proc. Soc. Exp. Biol. 210:64-76.
12. Huber, G. L., V. E. Pochay, W. Pereira, J. W. Shea, W. C. Hinds, M. W. First, and G. C. Sornberger. 1980. Marijuana, tetrahydrocannabinol, and pulmonary antibacterial defenses. Chest 77:403-410.
13. Sutton, S., B. L. Lum, and F. M. Torti. 1986. Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer. Drug Intelligence and Clinical Pharmacology 20:289-291.
14. Hamadeh, R., A. Ardehali, R. M. Locksley, and M. K. York. 1988. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest 94:432-433.
15. Marks, W. H., L. Florence, J. Lieberman, P. Chapman, D. Howard, P. Roberts, and D. Perkinson. 1996. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 61:1771-1774.
16. Newell, G. R., P. W. Mansell, M. B. Wilson, H. K. Lynch, M. R. Spitz, and E. M. Hersh. 1985. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Preventive Medicine 14:81-91.
17. Denning, D. W., S. E. Follansbee, M. Scolaro, S. Norris, H. Edelstein, and D. A. Stevens. 1941. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:654-662.
18. Caiaffa, W. T., D. Vlahov, N. M. Graham, J. Astemborski, L. Solomon, K. E. Nelson, and A. Munoz. 1994. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive infection drug users. Am. Rev. Respir. Dis. 150:1493-1498.
19. Ou, D. W., M.-L. Shen, and Y.-D. Luo. 1989. Effects of cocaine on the immune system of Balb/C mice. Clin. Immunol. Immunopathol. 52:305-312.
20. Chao, C. C., T. W. Molitor, G. Gekker, M. P. Murtaugh, and P. K. Peterson. 1991. Cocaine-mediated suppression of superoxide production by human peripheral blood mononuclear cells. J. Pharmacol. Exp. Therapeutics 256:255-258.
21. Delafuente, J. C., and C. L. DeVane. 1991. Immunologic effects of cocaine and related alkaloids. Immunopharmacol. Immunotox. 13:11-23.
22. Matsui, K., H. Friedman, and T. W. Klein. 1992. Cocaine augments proliferation of human peripheral blood T-lymphocytes activated with anti-CD3 antibody. Int. J. Immunopharmacol. 14:1213-1220.
23. Lefkowitz, S. S., A. Vaz, and D. L. Lefkowitz. 1993. Cocaine reduces macrophage killing by inhibiting reactive nitrogen intermediates. Int. J. Immunopharmacol. 15:717-721.
24. Shen, H. M., L. X. Sha, M. D. Wiederhold, and D. W. Ou. 1995. Suppression of macrophage reactive intermediates by cocaine. Int. J. Immunopharmacol. 17:419-423.
25. Peterson, P. K., G. Gekker, C. C. Chao, R. Schut, T. W. Molitor, and H. H. Balfour. 1991. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. J. Immunol. 146:81-84.
26. Bagasra, O., and R. J. Pomerantz. 1993. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J. Infect. Dis. 168:1157-1164.
27. Chaisson, R. E., P. Bacchetti, D. Osmond, B. Brodie, M. A. Sande, and A. R. Moss. 1989. Cocaine use and HIV infection in intravenous drug users in San Francisco. J.A.M.A. 261:561-565.
28. Chaisson, M. A., R. L. Stoneburner, D. S. Hildebrandt, W. E. Ewing, E. E. Telzak, and H. W. Jaffe. 1991. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 5:1121-1126.
29. Sherman, M. P., L. A. Campbell, H. Gong, Jr., M. D. Roth, and D. P. Tashkin. 1991. Respiratory burst and microbicidal characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers. Am. Rev. Respir. Dis. 144:1351-1356.
30. Van Dyke, C., A. Stesin, R. Jones, A. Chuntharapai, and W. Seaman. 1986. Cocaine increases natural killer cell activity. J. Clin. Invest. 77:1387-1390.
31. Baldwin, G. C., D. M. Buckley, M. D. Roth, E. C. Kleerup, and D. P. Tashkin. 1997. Acute activation of circulating PMNs following in vivo administration of cocaine: a potential etiology for pulmonary injury. Chest 111:698-702.
32. Fligiel, S. E. G., M. D. Roth, E. C. Kleerup, S. H. Barsky, M. S. Simmons, and D. P. Tashkin. 1997. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana and/or tobacco. Chest 112:319-326.
33. Baldwin, G. C., J. C. Gasson, S. G. Quan, J. Fleischmann, R. Weisbart, D. Oette, R. T. Mitsuyasu, and D. W. Golde. 1988. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc. Natl. Acad. Sci. U.S.A. 85:2763-2766.
34. Reynolds, H. Y. 1997. Integrated host defense against infections. In R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes, editors. The Lung: Scientific Foundations. Lippincott-Raven, New York. 2353-2366.
35. Huber, G. L., G. A. Simmons, C. R. McCarthy, M. B. Cutting, R. Laguarda, and W. Pereira. 1975. Depressant effect of marijuana smoke on antibactericidal activity of pulmonary alveolar macrophages. Chest 68:769-773.
36. Drath, D. B., J. M. Shorey, L. Price, and G. L. Huber. 1979. Metabolic and functional characteristics of alveolar macrophages recovered from rats exposed to marijuana smoke. Infect. Immun. 25:268-272.
37. Arata, S., C. Newton, T. Klein, and H. Friedman. 1992. Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages. Proc. Soc. Exp. Biol. Med. 199:65-67.
38. Brown, E. J. 1995. Phagocytosis. Bioessays 17:109-117.
39. Tahir, S. K., and A. M. Zimmerman. 1991. Influence of marihuana on cellular structures and biochemical activities. Pharmacol. Biochem. Behav. 40:617-623.
40. Tang, J. L., G. Lancz, S. Specter, and H. Bullock. 1992. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1. Int. J. Immunopharmacol. 14:253-262.
41. Martin, J. H. J., and S. W. Edward. 1993. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. J. Immunol. 150:3478-3486.
42. Ding, A., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
43. Kaplan, S. S., J. R. Lancaster, Jr., R. E. Basford, and R. L. Simmons. 1996. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect. Immun. 64:69-76.
44. Denis, M. 1994. Human monocytes and macrophages: NO or no NO? J. Leukocyte Biol. 55:682-684.
45. Michaliszyn, E., S. Senechal, P. Martel, and L. de Repentigny. 1995. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect. Immun. 63:2075-2078.
46. Kobzik, L., D. S. Bredt, C. J. Lowenstein, J. Drazen, B. Gaston, D. Sugarbaker, and J. S. Stamler. 1993. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9:371-377.
47. Chen, F., D. C. Kuhn, L. J. Gaydos, and L. M. Demers. 1996. Induction of nitric oxide and nitric oxide synthase mRNA by silica and lipopolysaccharide in PMA-primed THP-1 cells. Apmis 104:176-182.
48. de Vera, M. E., R. A. Shapiro, A. K. Nussler, J. S. Mudgett, R. L. Simmons, S. M. Morris, Jr., T. R. Billiar, and D. A. Geller. 1996. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. U.S.A. 93:1054-1059.
49. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380-387.
50. Cunha, F. Q., D. W. Moss, L. M. Leal, S. Moncada, and F. Y. Liew. 1993. Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology 78:563-567.
51. Tsuneyoshi, I., Y. Kanmura, and N. Yoshimura. 1996. Lipoteichoic acid from Staphylococcus aureus depresses contractile function of human arteries in vitro due to the induction of nitric oxide synthase. Anesthesia and Analgesia 82:948-953.
52. Coffey, R. G., Y. Yamamoto, E. Snella, and S. Pross. 1996. Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem. Pharmacol. 52:743-751.
53. Jeon, Y. J., K. H. Yang, J. T. Pulaski, and N. E. Kaminski. 1996. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation. Mol. Pharmacol. 50:334-341.
54. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319-326.
55. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.
56. Bonta, I. L., and S. Ben-Efraim. 1993. Involvement of inflammatory mediators in macrophage antitumor activity. J. Leukocyte Biol. 54:613-626.
57. Vaz, A., S. S. Lefkowitz, A. Castro, and D. L. Lefkowitz. 1994. The effects of cocaine and its metabolites on the production of reactive oxygen and reactive nitrogen intermediates. Life Sci. 55:439-444.
58. Nakabo, Y., and M. J. Pabst. 1996. Lysis of leukemic cells by human macrophages: inhibition by 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF). a serine protease inhibitor. J. Leukocyte Biol. 60:328-336.
59. Mao, J. T., M. Huang, J. Wang, S. Sharma, D. P. Tashkin, and S. M. Dubinett. 1996. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-γ production. Cell. Immunol. 172:217-223.
60. Thomassen, M. J., B. P. Barna, D. Rankin, H. P. Wiedemann, and M. Ahmad. 1989. Differential effect of recombinant granulocyte-macrophage colony-stimulating factor on human monocytes and alveolar macrophages. Cancer Res. 49:4086-4089.
61. Suzuki, K., W. J. Lee, T. Hashimoto, E. Tanaka, T. Murayama, R. Amitani, K. Yamamoto, and F. Kuze. 1994. Recomhinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex. Clin. Exp. Immunol. 98:169-173.
62. Kiertscher, S. M., and M. D. Roth. 1996. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukocyte Biol. 59:208-218.
63. Mullen, P. G., A. C. Windsor, C. J. Walsh, A. A. Fowler, III, and H. J. Sugarman. 1995. Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro. J. Surg. Res. 58:124-130.
64. Watson, C., S. Whittaker, N. Smith, A. J. Vora, D. C. Dumonde, and K. A. Brown. 1996. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin. Exp. Immunol. 105:112-119.
65. Roth, M. D., and S. H. Golub. 1993. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta-1 to suppress lymphocyte activation. J. Leukocyte Biol. 53:366-371.
66. Hoidal, J. R., J. G. White, and J. E. Repine. 1979. Influence of cationic local anesthetics on the metabolism and ultrastructure of human alveolar macrophages. J. Lab. Clin. Med. 93:857-866.
67. Duddridge, M., C. A. Kelly, C. Ward, D. J. Hendrick, and E. H. Walters. 1990. The reversible effect of lignocaine on the stimulated metabolic activity of bronchoalveolar lavage cells. Eur. Respir. J. 3:1166-1172.
68. Davidson, A. C., I. Barbosa, J. S. Kooner, A. S. Hamblin, T. C. Stokes, N. T. Bateman, and B. Gray. 1986. The influence of topical anaesthetic agent at bronchoalveolar lavage upon cellular yield and identification and upon macrophage function. Br. J. Dis. Chest 80:385-390.
69. Ferguson, R. P., J. Hasson, and S. Walker. 1989. Metastalic lung cancer in young marijuana smokers. J.A.M.A. 261:41-42.
70. Sridhar, K. S., W. A. Raub, N. L. Weatherber, L. R. Metsch, H. L. Surratt, J. A. Inciardi, R. C. Duncan, R. S. Anwyl, and C. B. McCoy. 1994. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J. Psychoactive Drugs 26:285-288.